EUVIMEDEUVIMED entdecken
Crossref

Tinosinenside A inhibits neuroinflammation and protects HT22 cells by suppressing the TLR4/NF-κB/NLRP3 signaling pathway in BV2 cells

Yongyan Xie, Yinfang Qin, Jingjing Wang, Ziwei Xu, Liping Chen, Yunxia Kuang, Ruwei Yang, Liping Huang

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-03828-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Yongyan Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Toll-Like Receptor 4, Anti-Inflammatory Agents, Neuroprotective Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: The Pharmacy first-class specialty construction funds in 14th Five-Year Plan Period of Jiangxi Province, the College Students' Innovation and Entrepreneurship…, the National Natural Science Foundation of China, the Development Plan of School-level Science and Technology Innovation Team of Jiangxi University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microglia-mediated neuroinflammation plays a crucial role in Alzheimer's disease (AD). Tinosinenside A (Tis A) is a novel sesquiterpene glycoside isolated from the dried rattan stem of Tinospora sinensis (Lour.) Merr. Tis A exhibited anti-inflammatory and neuroprotective activities in vitro. However, the mechanism underlying the inhibition of neuroinflammation and protection of nerve cells remains obscure. This study used lipopolysaccharide (LPS)-induced inflammatory response in BV2 cells to simulate a neuroinflammatory model and used Aβ1-42-induced HT22 cells to establish an AD cell model, aiming to investigate the efficacy and mechanism of Tis A through anti-neuroinflammation to protect nerve cells. Tis A had no effect on the proliferation of BV2 and HT22 cells at the tested concentrations. The time- and dose-dependent effects of Tis A on the LPS-induced inflammatory response of BV2 cells demonstrated that the best anti-inflammatory efficacy appeared after 12 h of pretreatment. Tis A inhibited the gene levels of TNF-α, IL-6, IL-1β, iNOS, and IL-10 while enhancing the gene levels of IL-4 and TGF-β. Additionally, Tis A reduced the gene expression levels of CD16 and CD32 and increased the CD36 and CD206 gene expression levels. It also downregulated the protein expression of Iba-1 and iNOS while upregulating CD206. Tis A obviously inhibited NLRP3 gene and protein expression in LPS-stimulated BV2 cells. The inhibitory effect of Tis A on NLRP3 was counteracted by the NLRP3 activator nigericin and overexpression plasmid GV358. Tis A inhibits NLRP3 protein expression to reduce the assembly of NLRP3/ASC/Caspase-1 inflammasome, then regulates the TLR4/NF-κB/NLRP3 signaling pathway. It regulates microglia activation and M1/M2 phenotypic polarization, then inhibits the production of inflammatory factors, and reduces the apoptosis rate of HT22 cells under inflammatory conditions, improving the survival rate of nerve cells to protect neurons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinToll-Like Receptor 4Anti-Inflammatory AgentsNeuroprotective AgentsSesquiterpenesNeuroinflammatory DiseasesAnimalsSignal TransductionMiceNF-kappa BCell LineAmyloid beta-PeptidesLipopolysaccharidesMicrogliaPeptide FragmentsCell Survival

Stichwörter der Autor:innen

MicrogliaNeuroinflammationTLR4/NF-κB/NLRP3Tinosinenside A

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinToll-Like Receptor 4NF-kappa BNlrp3 protein, mouseAnti-Inflammatory AgentsNeuroprotective AgentsTlr4 protein, mouseAmyloid beta-PeptidesSesquiterpenesLipopolysaccharides

Autor:innen und Institutionen

  • School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.
  • College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
  • School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China. jxnchlp@163.com.
  • Jiangxi Province Key Laboratory of Pharmacology of Traditional Chinese Medicine, Nanchang, 330004, China. jxnchlp@163.com.

Förderung

  • The Pharmacy first-class specialty construction funds in 14th Five-Year Plan Period of Jiangxi Province, the College Students' Innovation and Entrepreneurship…
  • the National Natural Science Foundation of China
  • the Development Plan of School-level Science and Technology Innovation Team of Jiangxi University of Chinese Medicine
  • Jiangxi Province Key Laboratory of Pharmacology of Traditional Chinese Medicine

Zitieren

APA

Xie, Y., Qin, Y., Wang, J., Xu, Z., Chen, L., Kuang, Y., Yang, R., & Huang, L. (2025). Tinosinenside A inhibits neuroinflammation and protects HT22 cells by suppressing the TLR4/NF-κB/NLRP3 signaling pathway in BV2 cells. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-03828-2

Vancouver

Xie Y, Qin Y, Wang J, Xu Z, Chen L, Kuang Y, et al. Tinosinenside A inhibits neuroinflammation and protects HT22 cells by suppressing the TLR4/NF-κB/NLRP3 signaling pathway in BV2 cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-03828-2

BibTeX
@article{Xie2025,
  author = {Xie, Yongyan and Qin, Yinfang and Wang, Jingjing and Xu, Ziwei and Chen, Liping and Kuang, Yunxia and Yang, Ruwei and Huang, Liping},
  title = {Tinosinenside A inhibits neuroinflammation and protects HT22 cells by suppressing the TLR4/NF-κB/NLRP3 signaling pathway in BV2 cells},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-03828-2}
}
Kostenlos starten →